The progression of breast cancer from the primary tumor setting to the metastatic setting is the critical event defining Stage IV disease, no longer considered curable. The microenvironment at specific organ sites is known to play a key role in influencing the ultimate fate of metastatic cells; yet microenvironmental mediated-molecular mechanisms underlying organ specific metastasis in breast cancer are not well understood. This review discusses biomimetic strategies employed to recapitulate metastatic organ microenvironments, particularly, bone, liver, lung and brain to elucidate the mechanisms dictating metastatic breast cancer cell homing and colonization. These biomimetic strategies include in vitro techniques such as biomaterial-based co-culturing techniques, microfluidics, organ-mimetic chips, bioreactor technologies, and decellularized matrices as well as cutting edge in vivo techniques to better understand the interactions between metastatic breast cancer cells and the stroma at the metastatic site. The advantages and disadvantages of these systems are discussed. In addition, how creation of biomimetic models will impact breast cancer metastasis research and their broad utility is explored.
(EMT) which confers them with a migratory and invasive phenotype enabling them to degrade the basement membrane and the vasculature eventually entering into blood circulation. 4 Following intravasation, several factors, such as physical/biochemical factors and BCC subtype, determine BCCs tropism to specific organs and their ultimate fate. For example, the lung, liver and bone are common metastatic sites because of the fenestrated vasculature at these sites, making it easy for the circulating cancer cells to exit the vasculature and colonize the organ. 5 Conversely, to colonize the brain, BCCs have to degrade the blood brain barrier. 5 Breast cancer subtype such as Luminal A/B (ER1 and/PR1), Luminal HER2 (ER1 and/ PR1 and HER21), HER2-enriched (ER-and PR-and HER21), basal triple negative (TN) (ER-and PR-and HER2-and EGFR1) and non-basal TN (ER-and PR-and HER2-and EGFR-) is also known to dictate its organ preference. [6] [7] [8] [9] [10] Bone is the preferred metastatic site in case of luminal A/B breast cancer subtypes whereas Luminal HER2 or HER2-enriched subtypes are associated with significantly higher rate of brain, liver and lung metastases. 6 Basal TN subtype is associated with higher brain, lung and nodal metastases whereas non-basal TN subtype is associated with higher brain, lung, nodal as well as liver metastases. 6 The primary tumor also secretes soluble factors, which induce modifications in the extracellular matrix (ECM) and co-opt existing vasculature of the distant organs forming a pre-metastatic niche enabling the homing and colonization of BCCs. 11, 12 However, many metastatic lesions, in particular to liver, lung and brain, can outgrow into non-angiogenic metastases. This, in turn, makes them less likely to respond to anti-angiogenic drugs. 12 After extravasation, cancer cells could survive and outgrow into a metastasis or undergo apoptosis. This largely depends on the ability of the cancer cells to acclimatize to the new organ environment indicated by Paget's "seed and soil" hypothesis proposed over a century ago. 11, [13] [14] [15] [16] Acclimatizing to the new soil is considered a rate-limiting step in metastasis. Furthermore, each organ has a unique ECM composition (e.g., abundance of collagen in bone/lung microenvironment) that could influence BCC-microenvironment interactions. Paracrine signaling facilitates the crosstalk between extravasated BCCs and the microenvironment. 17 This cross talk is critical in deciding the ability of the extravasated cells to undergo apoptosis or survive and subsequently grow into a metastatic lesion. Alternatively, extravasated BCCs might enter a dormant state and form metastasis years after extravasation. 18 Recent studies indicate that BCCs can metastasize even before the complete evolution of primary tumor and stay dormant at a metastatic site. For example, Harper et al. demonstrated that the HER21 BCCs disseminate to the metastatic site during early stages of primary tumor evolution and stay dormant. 19 This early dissemination was mediated by activation of Wnt-dependent EMT program implied in the formation of mammary ducts but without complete loss of the epithelial phenotype. 19 Similarly, Hosseini et al. demonstrated that the HER21 BCCs from early low density primary lesions exhibited enhanced migration and formed more metastases compared to BCCs from well-established primary tumors. 20 The study revealed that progesterone-induced signaling shortly after activation of HER21 led to increased migratory and metastatic potentials of BCCs during early evolution of the primary tumor. 20 This review focuses on the biomimetic strategies to recapitulate the microenvironment at the metastatic site, particularly, lung, liver, bone and brain for studying the mechanisms of breast cancer metastasis. Advances in coculturing techniques, microfluidics, organ on a chip, and bioreactor-based platforms have opened up new avenues for studying breast cancer metastasis in vitro. In addition, sophisticated ex vivo and mouse models have been devised. Collectively, these techniques are designed to mimic the microenvironment at the metastatic site enabling researchers to study the crosstalk between organ specific stromal cells and metastatic BCCs and evaluate the organ-homing potential of BCCs.
Biomimetic Strategies to Mimic the Bone Environment
Bone is one of the most preferred sites for breast cancer metastasis. 21, 22 To understand the events associated with bone metastasis, it is crucial to understand the metastatic niche in the bone marrow. Bone marrow niche consists of stromal cells, that is, hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), osteoblasts (OBs), osteoclasts (OCs) and adipocytes embedded in a collagen rich mineralized ECM. 23 The ECM also includes laminin, fibronectin and other adhesive proteins as well as proteoglycans like syndecan and perlecan. 24 HSCs secrete vascular endothelial growth factor (VEGF) which form a pre-metastatic niche for the BCCs. 25 This niche consists of thin vasculature predominantly made up of endothelial cells (ECs). Osteoblasts are also known to secrete CXCL12, which plays a key role in metastasis. 26 To understand the events leading to bone metastasis, biomimetic in vitro and in vivo approaches have been developed to mimic the bone metastatic niche.
Simple biomaterial based co-cultures for studying breast cancer bone metastasis (BCBM)
The most conventional approach to recapitulate the bone microenvironment is to culture bone marrow stromal cells (BMSCs) with BCCs. A popular approach is to use biomaterials such as Collagen, MatrigelV R , silk fibroin and polycaprolactone to synthesize hydrogels and/or scaffolds in which BMSCs and BCCs are co-cultured (studies summarized in Table 1 ). Tunability of stiffness, cyto-compatibility and chemical and morphological similarities to the natural basement membrane make these biomaterials good candidates for two dimensional (2D) and three dimensional (3D) co-cultures. 27 These simple biomaterial based co-cultures provide quick models to recapitulate the crosstalk between BCCs and BMSCs. For example, Marlow et al. modeled the dormancy 
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Narkhede et al. 29 The HUVECs formed microvascular network in the 3D culture system and the dormancy in MDA-MB-231 was confirmed by Ki-67 staining. The study identified thrombospondin-1 as an endothelium-derived tumor suppressor which confers dormancy in BCCs. 29 Following colonization, BCCs are known to affect the differentiation of bone marrow stem cells into osteoblasts and osteoclasts giving rise to a vicious cycle of BCBM. Biomaterials like silk fibroin support the differentiation of pre-osteoblasts and have been used to recapitulate the differentiation process of these cells in presence of BCCs. 30 MDA-MB-231 BCCs in presence of differentiating osteoblasts were found to secrete chemokines and cytokines such as IL-b, TGF-b and TNF-a which mediates the BCCs-OBs interaction. 30 To develop a more elaborate model, scientists have modeled the primary tumor and the secondary bone metastatic site simultaneously using co-culture techniques 31 (Fig. 1a) . This model provides a modular platform allowing incorporation of bone relevant physiology, such as rEnd matrix to recapitulate key aspects of bone endosteum, and liquid phase consisting of conditioned media from marrow cells to recapitulate paracrine signaling mediated by soluble factors. One can modify such a model to study the role of other key microenvironmental factors at the bone metastatic site. The main advantage of such model is that it recapitulates the primary and metastatic site simultaneously. Furthermore, this model could have applications in screening of the BCCs based on their invasive and metastatic potential (ability of BCCs to degrade ECM) and could help build personalized therapies. 31 However, the liquid phase consisting of conditioned media between the primary and metastatic site is stationary and hence the model does not account for the influence of shear on the metastatic BCCs. 31 Although studies using biomaterial based co-culture models are simple, they are valuable and continue to provide key insight into BCBM biology. However, these models usually do not recapitulate the natural architecture found in native bone. Also, they provide BCCs with direct access to the stromal cells and hence do not typically capture the initial crucial events of metastasis taking place at the bone site (advantages and disadvantages of the strategies summarized in Table 2 ).
Co-culture with live bone fragments for studying BCBM
To recapitulate the natural architecture of bone marrow, direct co-culture of live bone tissue fragments (BTFs) from CD-1 mice with MDA-MB-231 and MCF-7 BCCs has been investigated 32 ( Fig.1b; Table 1 ). This technique provides an intact natural bone architecture increasing the physiological relevance of co-culture models. Using such a model, enhanced proliferation and migration of MDA-MB-231 BCCs was observed when co-cultured with live human BTFs; the enhancement in proliferation and migration was attributed to chemokines and cytokines, derived from BMSCs in live human BTFs. 33 In a follow up study, 34 Such direct co-cultures with BTFs are good for short-term co-cultures due to limited viability of BTFs. Moreover, as BCCs are given direct access to BTFs, these systems do not recapitulate initial metastatic events at the bone. 35 In addition, such models usually do not allow investigator control of microenvironment factors making studies of the role of specific factors of the bone environment on metastatic cell homing and colonization relatively difficult.
3-D Mineralized biomaterial scaffolds for studying BCBM
Hydroxyapatite (HA) forms an inorganic component of bone marrow ECM. 36 To understand the role of HA in BCBM, mineralized scaffolds containing HA for 3D co-cultures of BMSCs and BCCs have been developed (Table 1) . Using these scaffolds, Ye et al. showed that HA adsorbs serum proteins on its surface, facilitating the adhesion and proliferation of MDA-MB-231 BCCs. 37 As HA adsorbs serum proteins, particle size, crystallinity and geometry of HA play a vital role in BCC adhesion. [38] [39] [40] [41] More recently, 3D printing techniques have been used to derive mineralized scaffolds of various geometries 40, 42 ( Fig. 1c) . Studies have also suggested that HA mediates the secretion of cytokines like TGF-b and IL-8 by BCCs in vitro, which in turn activates the osteoclasts leading to bone resorption. 43 Mineralized scaffolds closely mimic the vicious interaction between osteoblasts and BCC resulting in bone matrix resorption. Notably, the BCCs were found to be more susceptible to bisphosphonate treatment on mineralized scaffolds in the presence of osteoblasts. 44, 45 While these techniques incorporate the effects of HA in the bone ECM and provide key insights into interactions of BCCs with BMSCs in a mineralized environment, they are unable to capture the vicious cycle of bone metastasis due to limited culture time of 7-10 days because of early attainment of confluency and low matrix stability.
Bioreactor based co-cultures for studying BCBM
A longer co-culture time is typically necessary for recapitulating several aspects of BCC-BMSC interactions not captured by previously described techniques due to lower stability of biomaterial scaffolds, early attainment of confluency (monolayer culture) and limitations associated with renewal of nutrients. Bioreactors serve as a good platform for coculturing BCCs and BMSCs for longer time spans of up to 5 months (Table 1) . Bioreactors are vessels which facilitate dynamic long term 3D culture of mammalian cells with controlled nutrient delivery. Bioreactors are coupled with membrane dialysis, which facilitates the transfer of nutrients and metabolic waste into and out of the culture chamber respectively (Fig. 1d) . Multilayer co-cultures are possible in bioreactors; in these systems, BCCs do not have direct access to the stromal cells enabling a situation that recapitulates the early events of metastasis in the bone microenvironment. 46, 47 Longer culture time also facilitates the deposition of mineralized matrix by osteoblasts. Longer interaction of BCCs with differentiating osteoblasts and osteoclasts in bioreactors recapitulates the vicious cycle of metastasis and bone resorption. 46, 48, 49 Co-culture studies using bioreactors also captured the migration of BCCs towards osteoclasts. 50 In addition, bioreactor based co-cultures were able to recapitulate dormancy associated with BCCs in the bone marrow niche and showed that TNF-a and IL-b revoked BCCs from dormancy. 51 While bioreactors serve as a good platform for 
Microfluidic based co-cultures for studying BCBM
To study extravasation in the bone microenvironment, microfluidics approaches have been used for co-culturing BCCs, BMSCs and ECs (Table 1) . Microfluidic channels help in mimicking the bone vasculature and the stroma simultaneously. 52 This system helps to study the extravasation of BCCs under the influence of BMSCs (Fig. 1e) . Hence, microfluidics approaches provide significant advantage compared to the conventional Boyden chamber assays, wound healing assays and transwell assays to study BCC migration. In addition, the ability to perform real time imaging and mimic naturally occurring gradients pertaining to growth factors and shear forces increase their physiological relevance. Microfluidic devices have been used to demonstrate preferential BCCs' extravasation in the bone specific microenvironment highlighting the role of BMSCs in triggering the extravasation process. 53, 54 Chemokines secreted by BMSCs such as CXCL5 mediate the extravasation process through interaction with the chemokine receptor CXCR4 on BCCs. Application of microfluidics has also highlighted the effect of shear force generated by blood circulation on extravasation. 55 In particular, higher the shear force, lesser is the permeability of the vasculature. This observation is in line with the hypothesis that shear force tightens the endothelial cell junctions owing to realignment of actin filaments in the endothelial cells forming the vasculature. This finding suggests that BCCs can extravasate into the bone microenvironment at low shear zone in the bone vasculature. Overall, microfluidics enables the study of BCC extravasation in the bone microenvironment as it provides a biomimetic vascular construct allowing structured contact between bone marrow ECs and BCCs. Automated pumps can be utilized to mimic naturally occurring nutrient and growth factor gradients. However, microfluidic approach is limited by low cell numbers, very small operating volumes, stiff substrates and limited in situ tunability of culture conditions. 56 Hybrid in vivo models for studying BCBM Conventional in vivo xenograft or syngeneic models are popularly used to study BCBM. However, mouse organ microenvironment physiologically differs from humans and this must be considered while evaluating the results from this model. To overcome this drawback, researchers have integrated biomaterial based co-culture models with in vivo models. 57 We refer to them as hybrid in vivo models (Table 1) . In a general sense, a human bone mimicking microenvironment is created by culturing BMSCs on a biomaterial scaffold, which is subcutaneously implanted in mice creating a biomimetic metastatic site. This is followed by orthotopic injection of BCCs, which then colonize this scaffold in vivo. For example, silk scaffolds containing bone morphogenetic protein-2 (BMP-2) and BMSCs were implanted in NOD/SCID mice followed by the orthotopic injection of SUM1315 BCCs. 58 BCCs colonized the scaffold containing either one of BMP-2 or BMSCs compared to those containing both highlighting the balance and specificity needed between the environmental factors for BCC colonization. Incorporation of RANKL, which activates and regulate osteoclasts differentiation, also illustrates the effect of microenvironmental factors. Manipulation of silk scaffolds implanted in vivo through localized injections of RANKL led to osteoclast activation and upregulation of SDF-1/CXCR4 signaling, subsequently leading to greater BCC colonization followed by osteolysis. 59 Another study employed polycaprolactone (PCL) scaffolds seeded with osteoblasts and functionalized with BMP-2. This facilitated the formation of human bone tissue with vasculature in vivo, and enabled colonization of BCCs 60 ( Fig. 1f) . In a follow up study, these PCL scaffold mimics of human bone were used to study the effect of integrins on BCC colonization. 61 Researchers have also implanted tissue engineered or human derived bone into immunodeficient mice to study tissue tropism. Interestingly, implantation of human bone into mice resulted in BCCs colonizing the human bone and not the mouse skeletal bones. [62] [63] [64] Overall, hybrid in vivo models provide a platform to study organotropism of BCCs by coupling the cell-cell/matrix interactions in vivo. Tunability of tissue-engineered scaffolds implanted in vivo is a major advantage of this approach, while simultaneously retaining the benefits of mouse models.
Biomimetic Strategies to Mimic the Liver Environment
More than 50% of the patients diagnosed with breast cancer develop liver metastasis. 65 Liver presents a complex environment consisting of hepatic parenchymal cells (HPCs), hepatic non-parenchymal cells (NPCs) viz., sinusoidal endothelial cells, Kupffer cells and stellate cells. Liver ECM mainly comprises of collagen type-I and fibronectin with minor quantities of collagen Type-III, IV, V and VI. 66 The liver is mainly associated with metabolism of xenobiotics and drugs in the body. HPCs play a vital role in metabolism and NPCs assist HPCs in this process. Owing to its association with metabolism of drugs, the liver proves to be a very challenging site for antimetastatic chemotherapies. A crosstalk between HPCs and NPCs (like Von Kupffer cells) through secreted soluble factors such as chemokines and pro-inflammatory cytokines like IL-6, IL-8 and MCP-1, provides essential cues for the colonization of BCCs. 67 Liver microenvironment is also immunosuppressed for its normal functioning making it advantageous to BCCs as they can evade immune surveillance and colonize easily.
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Simple biomaterial based co-cultures for studying breast cancer liver metastasis (BCLM)
Direct co-cultures of hepatic cells with BCCs on a biomaterial-based platform provide a simple system to study BCC-hepatic niche interactions (Table 1) . For example, MDA-MB-231, MDA-MB-435 and MCF-7 cells co-cultured with rat hepatocytes on a collagen coated well plate recapitulated the mesenchymal to epithelial reverse transition associated with BCLM 69 (Fig. 2a) . A follow up study revealed that hepatocytes induce higher expression of E-cadherin in the BCCs leading to increased cell adhesion, proliferation and chemo resistance to therapeutics such as staurosporine (protein kinase inhibitor) and camptothecin (DNA topoisomerase inhibitor) through engaging ERK and Akt pathways. 70 Cocultures of BCCs with HPCs and NPCs, have suggested a role for HPCs in inducing dormancy in BCCs, while NPCs drive proliferation. 71 NPCs secrete soluble factors, which mediate cancer cell proliferation via paracrine signaling. 71 A major drawback of direct co-culture is its inability to maintain the metabolic ability of hepatocytes for a long time. 72 This makes it difficult to study the chemoresistance of BCCs in a physiologically relevant hepatic niche.
Microfluidics based co-cultures for studying BCLM
To overcome the drawback of biomaterial-based co-cultures, microfluidic approaches have been employed (Table 1) . The LiverChipV R is a commercially available microfluidic set up in which HPCs and NPCs can be co-cultured resulting in an ex-vivo functional liver micro-physiologic model (Fig. 2b) . This chip is equipped with an oxygen sensor and micropumps for controlled flow of nutrients and growth factors. Hepatocytes remain viable for about 15 days in this model maintaining their functionality. 68, 73 Using microfluidics platform, a recent study showed that the MDA-MB-231s and MCF-7 BCCs undergo spontaneous dormancy when cocultured with functional hepatic niche. 67 This was characterized by an increase in follistatin (a cancer attenuation marker) and decrease in pro-inflammatory signals viz., IGFBP-1, MCP-1, MIP-1a and IL-6. 67 Co-culturing BCCs with HPCs and NPCs in such a device provides an opportunity to study most of the events of metastatic cascade in the liver microenvironment. Cancer cells influence hepatocytes via paracrine signaling resulting in the alteration of chemotherapeutic metabolism, and this alteration is subject to naturally occurring gradients of nutrients and soluble factors. Therefore, therapeutic response in the liver can be effectively studied in microfluidic models, as it is possible to mimic the nutrient gradients in these devices. 74 Hybrid in vivo models for studying BCLM To closely recapitulate BCLM, hybrid in vivo models have also been devised wherein PCL scaffolds coated with decellularized liver matrix were subcutaneously implanted in murine models followed by orthotopic injection of BCCs 75 ( Fig. 2c) . BCCs showed increased colonization of scaffolds coated with diseased liver matrix compared to healthy liver matrix and this increased colonization was mediated by myeloperoxidase in the diseased liver matrix. These scaffolds can be used to trap the disseminated BCCs in vivo, which will eventually form liver metastasis and reduce the metastatic burden in the liver. In addition to studying BCLM, the hybrid in vivo approaches can be tailored to have diagnostic and therapeutic potential.
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Biomimetic Strategies to Mimic the Lung Environment
Lung is the second most common metastatic site for breast cancer. 78 Similar to bone and liver metastasis, lung microenvironment plays a crucial role in driving breast cancer lung metastasis (BCLuM).
Simple biomaterial based co-cultures for studying BCLuM
The most common approach to recapitulate the lung microenvironment is co-culturing lung epithelial cells with BCCs on a biomaterial platform (Table 1) . Collagen being the most abundant lung ECM protein is typically the first choice for these co-cultures. Apart from collagen (mainly Type I and III), lung ECM also consists of elastin, glycosaminoglycans, proteoglycans and fibronectin. 79, 80 A coculture model of lung epithelial cells (e.g., SAEC) with MDA-MB-231 and MCF-7 on rat tail collagen platform revealed that lung epithelial cells mediate the aggressive phenotype of MDA-MB-231 BCCs by triggering mesenchymal to epithelial transition as suggested by increased Ecadherin expression 81 ( Fig. 3a) . It was observed that SAECs confer senescence in MDA-MB-231 BCCs. 81 These observations clearly suggest that similar to hepatocytes, the normal lung epithelial cells in metastatic niche also provide progressive signaling which can promote BCC survival and dormancy. Similarly, a porous collagen scaffold seeded with lung epithelial cells and R221A mouse mammary tumor cells has been used to recapitulate the lung metastatic niche. 78 However, the conventional biomaterial based cocultures often fail to mimic the exact architecture of lung microenvironment in terms of their biophysical and biochemical properties. Co-culture on decellularized lung matrix for studying BCLuM
To overcome the drawback of biomaterial based co-cultures, an ex-vivo approach of culturing MDA-MB-231 and 4T1 BCCs on a decellularized lung matrix has been reported 82 (Table 1 ; Fig. 3b ). Lung tissue was procured from adult FVB mice and decellularized yielding a natural microenvironment with intact biophysical and biochemical properties (Fig. 3b) . Using this approach, Xiong et al. showed that the knockdown of Zeb1 gene significantly reduced the EMT process in BCCs cultured on decellularized lungs. 82 Based on incorporating either healthy or diseased lung tissue one can appropriately mimic the lung niche. Decellularization approach is widely used to study primary lung cancers but has started to gain popularity for studying breast cancer metastasis. 82 Decellularization approach enables the study of cell-cell/matrix interactions in naturally intact ECM architecture. In addition, this approach can also be employed to develop lung mimetic scaffolds which can integrated with murine models for studying BCLuM as demonstrated by Aguado et al.
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Biomimetic Strategies to Mimic the Brain Environment
Unlike other organs, BCCs find it challenging to colonize the brain tissue as they have to overcome the blood-brain barrier (BBB) during extravasation. 5 However, in many cases, aggressive breast cancers (especially TN and HER-2 positive breast cancers) are able to cross the BBB and colonize the brain. After extravasation through BBB, BCCs interact with the brain ECM which mainly comprises of glycosaminoglycans, proteoglycans and glycoproteins. 83 Following brain metastasis, median survival of patient drops asymptotically because anti-metastatic therapies cannot be effectively transported across the BBB. 84 In vitro BBB models for studying breast cancer brain metastasis (BCBrM)
To understand BCBrM, efforts have been directed towards modeling the BBB in vitro (Table 1) . BBB consists of tightly packed brain microvascular endothelial cells that form the vasculature, surrounded by pericytes in contact with the brain parenchyma consisting of astrocytes. The transwell assay has been modified to mimic the multilayered architecture of BBB (Fig. 4a) . In general, endothelial cells are seeded on top of the insert membrane (luminal side) and pericytes on the bottom with astrocytes usually cultured in the wells (abluminal side). Together, the insert and the well act as an in vitro BBB model. This model is modular and can also be coupled with permeability measuring techniques for capturing permeability changes of the in vitro BBB. 85 Using such a model, studies have elucidated how COX2, heparin binding epithelial growth factors, epiregulins, cancer associated fibroblasts and BCC derived extracellular vesicles (e.g., microRNA-181c-containing extracellular vesicles) lower the permeability of BBB facilitating BCC extravasation. [86] [87] [88] The source of endothelial cells is also important in studying BCBrM as reported by the comparative analysis of various BBB in vitro models using endothelial cells derived from bovine, mice and human respectively. 85 In vitro BBB models can also be created by utilizing microfluidics approaches. For example, Xu et al. constructed an in vitro BBB model using a microfluidic chip by systematically co-culturing endothelial cells and astrocytes in microfluidic channels to examine the extravasation of MDA-MB-231 BCCs. 89 The in vitro BBB models serve as a modular platform to study BCBrM providing flexibility to include various components of brain stroma. In vitro BBB models are mainly cellular constructs assembled in 2D and hence their physiological relevance is limited. 90 Although the in vitro BBB models incorporate the cellular components such as endothelial cells, pericytes and astrocytes, there is scope for the incorporation of microglial cells which function as macrophages and are involved in the damage response. Microglial cells are known to exert pro-tumoral effects by secreting cytokines and growth factors and promote colonization of brain tissue by BCCs. [91] [92] [93] [94] Co-culture with brain slices to study BCBrM
In addition to BBB models, co-culture of BCCs with mouse brain slices have been studied which revealed that BCCs activate microglia and astrocytes to invade the brain tissue. [95] [96] [97] [98] (Fig. 4b) . BCCs migrate under influence of soluble factors secreted by reactive microglia. [95] [96] [97] Co-culturing the BCCs with live brain tissue provides a quick approach to study BCBrM, while simultaneously providing natural brain architecture and components to the BCCs. The issue of limited microenvironment complexity provided by in vitro BBB models is overcome by this approach. However, as live brain tissues are used, cultures cannot be maintained for longer times and matrix tunability is limited.
Conclusions
To examine the mechanisms associated with breast cancer metastasis, biomimetic strategies to recapitulate the organ microenvironment are crucial. The native organ microenvironment is highly complex. However, biomimetic strategies, such as those highlighted here, suggest a reductionist approach of recapitulating one or more aspect of this microenvironment. Such an approach helps in decoupling the effects of specific signals present in the tumor microenvironment on breast cancer cell fate. For example, microfluidics have been mainly used to study extravasation of BCCs in a specific microenvironment pertaining to a metastatic site highlighting cell-cell interactions whereas biomaterial based co-cultures have been used to study cell-cell/matrix interactions. Each technique has its own advantages and limitations and thus the results from the system and its physiological relevance must be evaluated considering these aspects.
Overall, development of biomimetic strategies to recapitulate organ environments to study breast cancer metastasis is an active area of investigation. Whereas several models have been developed in the context of bone metastasis, relatively fewer models exist in the context of liver, lung and brain metastasis. Future research would likely focus on developing such models. In addition, future work will likely be focused on increasing the physiological relevance of these models. For example, secreted vesicles (exosomes) can be incorporated into these 3D biomimetic strategies as they are implied in cancer metastasis and organotropism. 99, 100 Also, immune cells are known to interact with cancer cells via paracrine signaling and enhance their migratory and invasive potential.
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3D in vitro models to recapitulate tumor-immune interactions at primary tumor site have been developed. [102] [103] [104] [105] [106] However, current 3D in vitro metastasis models do not largely recapitulate tumor-immune interactions at the metastatic site. In future, the relevance of 3D in vitro metastasis models can be improved by incorporating immune cells prevalent at the metastatic site (viz., myeloid cells, bone marrow progenitor cells, macrophages). In addition, current 3D in vitro metastasis models typically incorporate HUVECs to recapitulate tumor-endothelium interactions. However, recent findings suggest that endothelial cells at particular organ have evolved to perform organ specific function such as providing organ specific angiocrine factors. 107 Therefore, it would be worthwhile to incorporate organ/tissue specific endothelial cells for increasing physiological relevance of 3D in vitro metastasis models for study tumor-endothelium interactions. Future metastasis models should also focus on the impact of in vitro culture conditions on the physiological behavior of endothelial cells. Perhaps, some of these strategies could be employed as drug screening platforms and subsequently for developing personalized medicine. Future studies addressing the challenges associated with adopting and validating these biomimetic strategies for high throughput drug screening are awaited.
